Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 01, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Systemic Lupus Erythematosus Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight

New York, USA, April 01, 2026 (GLOBE NEWSWIRE) -- Systemic Lupus Erythematosus Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Developing Drugs for Market Entry |...
January 19, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Tenosynovial Giant Cell Tumors Market to Show Significant Growth by 2034 as CSF1R-Targeted Therapies Drive the Next Wave | DelveInsight

New York, USA, Jan. 19, 2026 (GLOBE NEWSWIRE) -- Tenosynovial Giant Cell Tumors Market to Show Significant Growth by 2034 as CSF1R-Targeted Therapies Drive the Next Wave | DelveInsight The...
January 13, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Systemic Lupus Erythematosus Market to Exhibit Growth at a CAGR of 9.4% During the Forecast Period (2025–2034) Owing to Rising Use of Biologics – Approvals of BENLYSTA and SAPHNELO, Plus a Strong Pipeline | DelveInsight

New York, USA, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Systemic Lupus Erythematosus Market to Exhibit Growth at a CAGR of 9.4% During the Forecast Period (2025–2034) Owing to Rising Use of Biologics –...
October 27, 2025 08:00 ET | Source: Evaxion

Evaxion appoints Dr Helen Tayton-Martin as new Chief Executive Officer

Dr Tayton-Martin brings broad experience of biotech company building, fund-raising, M&A, business development and operations with a strong track record of strategic partnership dealsHer more than...
August 25, 2025 15:00 ET | Source: DelveInsight Business Research LLP

Non-cystic Fibrosis Bronchiectasis Market Ready to Shift Gears with the Entry of First DPP1 Blocker | DelveInsight

New York, USA, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Non-cystic Fibrosis Bronchiectasis Market Ready to Shift Gears with the Entry of First DPP1 Blocker | DelveInsight Insmed’s BRINSUPRI (brensocatib)...
August 06, 2025 01:30 ET | Source: Galapagos NV

Galapagos NV kondigt aan dat GLPG5101 de status van Regenerative Medicine Advanced Therapy (RMAT) van de FDA krijgt voor de behandeling van recidief/refractair mantelcellymfoom

Mechelen, België; 6 augustus 2025, 7.30 uur CET; gereglementeerde informatie – voorwetenschap – Galapagos NV (Euronext & NASDAQ: GLPG) kondigde vandaag aan dat de Amerikaanse Food and Drug...
August 06, 2025 01:30 ET | Source: Galapagos NV

Galapagos NV Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to GLPG5101 for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma

Mechelen, Belgium; August 6, 2025, 7:30 CET; regulated information – inside information – Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the United States Food and Drug Administration...
June 12, 2025 13:00 ET | Source: DelveInsight Business Research LLP

Giant-Cell Arteritis Market Heats up with AbbVie’s RINVOQ Approval | DelveInsight

New York, USA, June 12, 2025 (GLOBE NEWSWIRE) -- Giant-cell Arteritis Market Heats up with AbbVie’s RINVOQ Approval | DelveInsight The FDA has approved AbbVie’s RINVOQ (upadacitinib) for the...
June 10, 2025 13:00 ET | Source: DelveInsight Business Research LLP

Fabry Disease Market to Grow Rapidly During the Study Period (2020–2034) | DelveInsight

New York, USA, June 10, 2025 (GLOBE NEWSWIRE) -- Fabry Disease Market to Grow Rapidly During the Study Period (2020–2034) | DelveInsight The Fabry disease market is growing due to rising...
March 28, 2025 16:30 ET | Source: Traws Pharma, Inc.

Traws Pharma Announces Management Updates

Werner Cautreels, PhD, to retire as CEO, while continuing as a Board MemberIain D. Dukes, D Phil, Executive Board Chairman, to become Interim CEO NEWTOWN, Pa., March 28, 2025 (GLOBE NEWSWIRE) --...